Brief: Bioxcel Therapeutics Regains Compliance With Nasdaq Market Value Of Listed Securities Requirements
18/09/2025 14:27
Sept 18 (Reuters) - BioXcel Therapeutics Inc BTAI.O: BIOXCEL THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ MARKET VALUE OF LISTED SECURITIES REQUIREMENTS Source text: ID:nGNX6kJxl0 Further company coverage: BTAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty